4.4 Article

Artificial Macrocycles

Journal

SYNLETT
Volume 29, Issue 9, Pages 1136-1151

Publisher

GEORG THIEME VERLAG KG
DOI: 10.1055/s-0036-1591975

Keywords

macrocycle; multicomponent reaction; bioavailability; convergence; bioactivity; druglike properties; synthetic pathway; property space

Funding

  1. NIH [NIH 2R01GM097082-05]
  2. Innovative Medicines Initiative Joint Undertaking [115489]
  3. European Union
  4. European Union's Horizon research and innovation programme under MSC ITN 'Accelerated Early stage drug dIScovery' (AEGIS) [675555]
  5. Egypt government
  6. KWF [10504]

Ask authors/readers for more resources

Artificial macrocycles recently became popular as a novel research field in drug discovery. As opposed to their natural twins, artificial macrocycles promise to have better control on synthesizability and control over their physicochemical properties resulting in drug like properties. Very few synthetic methods allow for the convergent, fast but diverse access to large macrocycles chemical space. One synthetic technology to access artificial macrocycles with potential biological activity, multicomponent reactions, is reviewed here, with a focus on our own work. We believe that synthetic chemists have to acquaint themselves more with structure and activity to leverage the design aspect of their daily work. 1 Introduction 2 Macrocycle Properties and Receptor Binding 3 Synthetic Approaches towards Artificial Macrocycles Using MCR 4 Design Rules for Membrane Crossing Macrocycles 5 Design Rules for Libraries of Macrocycles 6 Computational Macrocyclic Methods 7 Future View

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available